Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.29 HKD | +11.21% | +0.79% | -43.61% |
Business Summary
Number of employees: 230
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical Products
100.0
%
| 560 | 100.0 % | 513 | 100.0 % | -8.44% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China (excluding Hong Kong and Taiwan)
79.8
%
| 554 | 99.0 % | 409 | 79.8 % | -26.17% |
France
17.8
%
| - | - | 91 | 17.8 % | - |
Others
2.3
%
| 6 | 1.0 % | 12 | 2.3 % | +114.00% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jian Xin Yang
CEO | Chief Executive Officer | 60 | 16-11-30 |
Jun Cheng
DFI | Director of Finance/CFO | 44 | 22-02-28 |
Ying Hua Zhang
COO | Chief Operating Officer | 44 | 16-07-31 |
Wei Cong Ni
SEC | Corporate Secretary | - | 18-07-31 |
Sanhu Wang
LAW | General Counsel | 53 | 19-05-31 |
Shirley Zhao
PRN | Corporate Officer/Principal | - | 19-12-05 |
Michael J. Choi
PRN | Corporate Officer/Principal | 53 | 21-04-30 |
Yin Kwan Ho
SEC | Corporate Secretary | 47 | 22-07-27 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Edward Hu
BRD | Director/Board Member | 61 | 21-07-08 |
Wei Li
BRD | Director/Board Member | 52 | 18-09-30 |
Ting Yuk Wu
BRD | Director/Board Member | 69 | 19-02-13 |
Hong Bin Sun
BRD | Director/Board Member | 48 | 19-02-13 |
Director/Board Member | 72 | 19-02-13 | |
Xiang Hong Lin
BRD | Director/Board Member | 53 | 20-11-29 |
Jian Xin Yang
CEO | Chief Executive Officer | 60 | 16-11-30 |
Kenneth Hitchner
BRD | Director/Board Member | 63 | 21-12-09 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,284,191,212 | 671,619,222 ( 52.30 %) | 0 | 52.30 % |
Company contact information
CStone Pharmaceuticals Co. Ltd.
North Block Suzhou Industrial Park 218 Xinghu Street
200126, Shanghai
+86 512 8718 6550
http://www.cstonepharma.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.61% | 189M | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- 2616 Stock
- Company CStone Pharmaceuticals